Black, Hispanic and female patients with ulcerative colitis were significantly less likely to undergo colectomy compared with ...

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...

New long-term data from Eli Lilly and Company (NYSE: LLY) show patients with moderately to severely active ulcerative colitis (UC) treated with Omvoh (mirikizumab-mrkz) achieved durable disease ...

Even with biologics changing the treatment paradigm for ulcerative colitis more than 2 decades ago, patients have a similar ...

LUCENT-3 trial open-label extension data show 63.5% of adults with ulcerative colitis administered mirikizumab (Omvoh) who ...

Use of NSAIDs is not associated with an increased risk for disease-related hospitalization in ulcerative colitis, although a small increase is observed in Crohn’s disease.

Lilly's Omvoh is the first and only IL-23p19 to demonstrate durable disease clearance in ulcerative colitis through four years: Indianapolis Wednesday, May 6, 2026, 09:00 Hrs [IST ...

But the 26-year-old, from Arnold in Nottinghamshire, has found life with a stoma - a surgical opening in her intestines ...

If you’ve been trying to control ulcerative colitis (UC), you’re probably looking forward to the day your doctor says you’re in remission. “When you start UC treatment, the first goal is just … to ...

You’ve followed your ulcerative colitis (UC) treatment plan to a T, and yet you’re still experiencing symptoms that won’t let up — or even seem to be taking a turn for the worse. There’s an ...

Cristcot, a clinical-stage pharmaceutical company advancing targeted therapies for gastrointestinal diseases, today announced that the Company will present its abstract evaluating the impact of ...

For millions with IBD, eating can be complicated. But these empowering, expert-backed tips help bring confidence and control ...